Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma

SK Gautam, SK Batra, M Jain - Molecular cancer, 2023 - Springer
Immunosuppression is a hallmark of pancreatic ductal adenocarcinoma (PDAC),
contributing to early metastasis and poor patient survival. Compared to the localized tumors …

Advances in sensor developments for cell culture monitoring

KR Kim, WH Yeo - BMEMat, 2023 - Wiley Online Library
Cell culture encompasses procedures for extracting cells from their natural tissue and
cultivating them under controlled artificial conditions. During this process, various factors …

Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy

X Wang, R Fan, M Mu, L Zhou, B Zou, A Tong… - Trends in Cell Biology, 2024 - cell.com
The efficacy and safety of chimeric antigen receptor (CAR) T cell therapy is still inconclusive
in solid tumor treatment. Recently, nanotechnology has emerged as a potent strategy to …

Training the next generation of researchers in the Organ-on-Chip field

A Moruzzi, T Shroff, S Keller, P Loskill, M Cipriano - Education Sciences, 2023 - mdpi.com
Organ-on-chip (OoC) technology bridges the principles of biology and engineering to create
a new generation of in vitro models and involves highly interdisciplinary collaboration across …

Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy

S Dey, M Kinoshita, S Puttick, S Rose… - Advanced Sensor …, 2024 - Wiley Online Library
Precision radiotherapy, such as targeted radioligand therapy, accentuates the precise
delivery of radiation to tumor cells while limiting radiation damage to surrounding normal …

Continuous inline monitoring of glucose in an organ-on-chip using FreeStyle™ libre glucometers

MG Sánchez-Salazar, R Garza-Garza… - Frontiers in Lab on a …, 2024 - frontiersin.org
Introduction: Organ-on-chips have become an effective platform for studying the physiology
of tissues and organs and for evaluating the safety and efficacy of drugs. In these systems …

Improving tumor microenvironment assessment in chip systems through next-generation technology integration

D Gaebler, SJ Hachey, CCW Hughes - Frontiers in Bioengineering …, 2024 - frontiersin.org
The tumor microenvironment (TME) comprises a diverse array of cells, both cancerous and
non-cancerous, including stromal cells and immune cells. Complex interactions among …

Hybrid-integrated devices for mimicking malignant brain tumors (“tumor-on-a-chip”) for in vitro development of targeted drug delivery and personalized therapy …

TM Zimina, NO Sitkov, KG Gareev… - Frontiers in …, 2024 - frontiersin.org
Acute and requiring attention problem of oncotheranostics is a necessity for the urgent
development of operative and precise diagnostics methods, followed by efficient therapy, to …

Enhancing the Treating Efficacy of Immunotherapy through the Restructure of Tumor Microenvironment

B Gong, W Jia, Y Zhou, Y Xu, Y Wei… - Advanced NanoBiomed …, 2023 - Wiley Online Library
The therapeutic modes of cancers have been profoundly renovated by immunotherapies,
which have shown extraordinary treating efficacy in certain tumor entities. However, the …

Precision Medicine Based on Real-time Immune Status Profiling Utilizing Novel Nanoparticles and Engineered Nanomaterials

Y Cai - 2023 - etd.auburn.edu
Cancer treatment strategies such as Anti-programmed death-ligand 1 (Anti-PD-L1) or
chimeric antigen receptors (CAR) T-cells are limited by low objective response rates and …